At Reprogram Biosciences, cell reprogramming is at the center of a new way of thinking about therapeutics. Below, Rustam Esanov (CEO) and Eziz Kuliyev (COO) from Reprogram Bio shares—in their own words—how the team is approaching this shift, where they are focusing first, and how partnering with Helix has helped accelerate their work.​ Reprogram’s Mission and Current Focus “To start, could you give a quick overview of Reprogram Biosciences and what your current main project

Dan Peer - Vice President for Research and Development at Tel Aviv University, Founder of NeoVac Introducing Peer Professor Dan Peer, a...